Glucocorticoids in acute pancreatitis: A propensity score matching analysis
BMC Gastroenterology Aug 30, 2021
Wang M, Jiang Z, Liang H, et al. - Glucocorticoids are supported to have beneficial effects in the treatment of acute pancreatitis.
The final analysis was performed including a total of 818 eligible patients with acute pancreatitis.
Glucocorticoids were used in treating 76 patients, but not in 742 patients.
Before propensity score matching, the GC group had significantly higher triglyceride levels (38.2 ± 18.5 vs 20.2 ± 16.8) and Acute Physiology and Chronic Health Evaluation II (APACHE II) scores (7.1 ± 2.5 vs 4.5 ± 2.1) at admission, as well as had significantly higher incidence of multi-organ failure (33.3% vs 11.9%), compared with the NGC group.
After 1:1 propensity score matching, the analysis included 59 patients from each group (GC and NGC) and the GC group had a significantly lower proportion of patients with organ failure (40.7% vs 52.5%) and multi-organ failure (35.0% vs 67.7%) and had significantly shorter lengths of hospital stay (12.9 ± 5.5 vs. 16.3 ± 7.7) and costs (25,348.4 ± 2512.6 vs 32,421.7 ± 2813.3) compared with those in the NGC group.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries